Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 15, 2018
Desert Oasis Healthcare and Proteus Digital Health announced a multi-year collaboration established with a value-based contract.
read more
Ology Bioservices announced the Department of Defense has awarded the company with two contracts valued at $135.4 million.
read more
Tuesday, February 17, 2026
Capricorn Scientific has expanded its European operations with a new 4,000m² logistics and infrastructure hub in Ebsdorfergrund, Germany.
read more
Reaction Biology Corporation has received a subcontract from Leidos Biomedical Research, which operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute.
read more
Clinigen Group announced its Idis Global Access division, has signed three further exclusive agreements to manage the supply and distribution of critical medicines on demand.
read more
Thursday, January 16, 2020
Argonaut Manufacturing Services has announced the recent launch of their state-of-the-art aseptic vial filling services.
read more
Thursday, November 01, 2012
Local and state government officials joined representatives from Eli Lilly and Company today to announce a $140 million expansion to the company's Indianapolis insulin manufacturing operations. The 80,000-square-foot expansion, which will enable the...
read more
VectorBuilder plans to invest $50 million to build an Advanced Biomanufacturing and R&D Center in Chicago, significantly expanding its U.S. presence and support for genetic medicine development.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Friday, September 27, 2019
Translate Bio has entered into a multi-year strategic manufacturing agreement with AMRI in support of the planned expansion of Translate Bio’s cGMP clinical mRNA manufacturing capabilities.
read more
Wednesday, April 22, 2020
Cellphire announced the BARDA has exercised its third contract option valued at $33.3 million to support Cellphire's next generation platelet-based hemostatic product, Thrombosomes.
read more
Aleafia Health’s indirect subsidiary, Emblem Germany GmbH, has formally submitted its application to German regulators for EU Good Manufacturing Practices (EU-GMP) certification.
read more
Wednesday, November 27, 2013
CPhI Worldwide, organised by UBM Live, celebrates the closing of its most successful show to date with pre-audit figures estimating more than 34,000 attendees and 2,200 exhibitors. Held in Frankfurt, the show hosted senior-level decision makers and ...
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
BioMarin shares neared an all-time high after announcing positive results from a mid-stage study for its drug to treat the most common form of dwarfism.
read more